The populations that could benefit most from obesity therapies and clinical trial participation, often live in regions with limited access to major research centers or academic hospitals
CrossRef Engineered Lactococcus lactis secreting a glucagon-like peptide-1-inducing protein P9 for amelioration of obesity in mice Wenxuan Di, Xiaoyue Bai, Shuangrui Tian, Liang Zhao, Xi Cao, Yanling Hao, Zhengyuan Zhai 3 Biotech.2025;[Epub] CrossRef Novel therapies IMID Co-morbidities Tsz On Lam, Ho So, Lai-Shan Tam Best Practice & Research Clinical Rheumatology.2025
Are weight loss medications safe for long-term use
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Ready to go
The leading widespread human exposure to toxins harms reproductive health in both males and females (particularly affecting ovarian function and contributing to PCOS-like symptoms) [14]